ACD PHARMACEUTICALS AS

8370 LEKNES

Finances

Share Ownership

Return on Equity

−87,19 %

Current Ratio

4,55

Debt-to-Equity Ratio

0,36

Key figures (NOK)	2022	2021	2020	2019
Revenue	26 850 000	12 706 000	17 080 000	20 026 000
Net Income	−12 271 000	1 145 000	9 116 000	10 437 000
Total Assets	24 283 000	16 204 000	25 535 000	16 204 000
Total Equity	14 074 000	13 034 000	11 889 000	2 773 000

Income (NOK)	2022	2021	2020	2019
Revenue	26 850 000	12 706 000	17 080 000	20 026 000
Expenditure	42 807 000	12 656 000	5 759 000	9 826 000
Operating Profit	−15 957 000	1 285 000	11 322 000	10 200 000
Financial Income	150 000	16 000	178 000	2 322 000
Financial Costs	187 000	42 000	−23 000	88 000
Financial Balance	−37 000	−26 000	201 000	2 234 000
Earnings Before Tax	−15 994 000	1 260 000	11 523 000	12 434 000
Tax	−3 723 000	115 000	2 407 000	1 997 000
Net Income	−12 271 000	1 145 000	9 116 000	10 437 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 103 000	3 673 000	113 000	147 000
Total Current Assets	23 180 000	12 531 000	25 422 000	16 057 000
Total Assets	24 283 000	16 204 000	25 535 000	16 204 000
Total Retained Equity	463 000	12 734 000	11 589 000	2 473 000
Total Equity	14 074 000	13 034 000	11 889 000	2 773 000
Total Long-Term Debt	5 110 000	0	11 000	1 000
Total Current Debt	5 099 000	3 171 000	13 636 000	13 430 000
Total Equity and Debt	24 283 000	16 204 000	25 535 000	16 204 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	26 388 000	12 706 000	17 080 000	20 026 000
Other Income	463 000	0	0	0
Revenue	26 850 000	12 706 000	17 080 000	20 026 000
Cost of Goods Sold	2 707 000	46 000	0	581 000
Salary Costs	14 282 000	4 581 000	105 000	3 923 000
Depreciation	97 000	34 000	34 000	28 000
Impairment	0	0	0	0
Expenditure	42 807 000	12 656 000	5 759 000	9 826 000
Operating Profit	−15 957 000	1 285 000	11 322 000	10 200 000
Financial Income	150 000	16 000	178 000	2 322 000
Financial Costs	187 000	42 000	−23 000	88 000
Financial Balance	−37 000	−26 000	201 000	2 234 000
Dividends	0	0	0	10 000 000
Net Income	−12 271 000	1 145 000	9 116 000	10 437 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	2 000	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	3 592 000	0	0
Fixtures	1 103 000	79 000	113 000	147 000
Total Tangible Assets	1 103 000	3 671 000	113 000	147 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 103 000	3 673 000	113 000	147 000
Stock	568 000	125 000	0	0
Total Investments	0	0	0	0
Cash, Bank	1 674 000	10 203 000	10 422 000	141 000
Total Current Assets	23 180 000	12 531 000	25 422 000	16 057 000
Total Assets	24 283 000	16 204 000	25 535 000	16 204 000
Total Equity	14 074 000	13 034 000	11 889 000	2 773 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	5 110 000	0	11 000	1 000
Creditors	1 923 000	2 208 000	1 232 000	744 000
Unpaid Taxes	1 022 000	399 000	0	224 000
Dividends	0	0	0	10 000 000
Other Current Debt	2 154 000	435 000	10 006 000	467 000
Total Current Debt	5 099 000	3 171 000	13 636 000	13 430 000
Total Equity and Debt	24 283 000	16 204 000	25 535 000	16 204 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−87,19 %	8,78 %	76,68 %	376,38 %
Debt-to-Equity Ratio	0,36	0	0	0
Operating Profit Margin	−59,43 %	10,11 %	66,29 %	50,93 %
Current Ratio	4,55	3,95	1,86	1,2
Quick Ratio	5,12	4,11	1,86	1,2
Equity Ratio	0,58	0,8	0,47	0,17
Gross Profit Margin	89,92 %	99,64 %	100 %	97,1 %